Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus eye drops and PRP for chronic dry eye
IRCT20211011052725N1Phase 2Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Jan 2022
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of tacrolimus in dry eye syndrome (DED) (3 arms), sponsored by Kerman University of Medical Sciences. Primary endpoints: Tear breakup time test, Corneal staining and 1 more. Started Jan 2022; status: completed.
02
Drugs
tacrolimus
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on IRCT20211011052725N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211011052725N1.